Sign in

CIK 0001159036 · Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880488686
Phone
(858) 794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,884,955
in 5 filings, $19.9M under 10b5-1 plans

Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-10-02 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −2,400 $72.07 $173K 734,519
2025-10-02 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −700 $73.24 $51K 733,819
2025-10-02 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −100 $74.67 $7K 733,719
2025-10-02 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162K 96,569
2025-10-01 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $8.11 $162K 753,719
2025-10-01 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −11,705 $75.11 $879K 742,014
2025-10-01 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −8,295 $75.69 $628K 733,719
2025-10-01 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $8.11 $162K 116,569
2025-10-01 Connaughton Bernadette Director Sale 10b5-1 −1,500 $75.09 $113K 45,452
2025-10-01 Connaughton Bernadette Director Sale 10b5-1 −500 $75.70 $38K 44,952
2025-09-22 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale 10b5-1 −1,913 $77.83 $149K 22,393
2025-09-22 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale 10b5-1 −314 $78.67 $25K 22,079
2025-09-10 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Option exercise 10b5-1 +11,271 $12.07 $136K 43,171
2025-09-10 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Option exercise 10b5-1 +1,135 $12.49 $14K 44,306
2025-09-10 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale 10b5-1 −6,760 $75.29 $509K 37,546
2025-09-10 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale 10b5-1 −13,240 $75.93 $1.0M 24,306
2025-09-10 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Option exercise · Option to Purchase Common Stock 10b5-1 −11,271 0
2025-09-10 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Option exercise · Option to Purchase Common Stock 10b5-1 −1,135 812
2025-09-04 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $8.11 $162K 753,719
2025-09-04 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −9,900 $73.54 $728K 743,819

Page 15 of 26 · 513 trades